Ovid Therapeutics (NASDAQ:OVID) Shares Down 6.1% After Earnings Miss
Ovid Therapeutics (NASDAQ:OVID – Get Free Report) dropped 6.1% on Tuesday following a dissappointing earnings announcement. The stock traded as low as $2.65 and last traded at $2.6750. Approximately 350,608 shares traded hands during trading, a decline of 85% from the average daily volume of 2,305,716 shares. The stock had previously closed at $2.85. The […]
10 Nov 15:21 · The Markets Daily